Kelamoxil LA 150 mg/ml suspension for injection for cattle and pig
Kelamoxil LA 150 mg/ml suspension for injection for cattle and pig
Authorised
- Amoxicillin
Product identification
Medicine name:
Kelamoxil LA 150 mg/ml suspension for injection for cattle and pig
Kelamoxil LA 150 mg/ml szuszpenziós injekció szarvarmarhák és sertések részére
Active substance:
- Amoxicillin
Target species:
-
Cattle
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Amoxicillin150.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
Meat and offal18day
-
Milk72hour
-
- Pig
-
Meat and offal20day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Available in:
-
Hungary
Package description:
- Clear PET vial of 250 ml closed with type I laminated chlorobutyl rubber stopper and aluminium cap in a carton box
- Clear PET vial of 100 ml closed with type I laminated chlorobutyl rubber stopper and aluminium cap in a carton box
- Clear type II glass vial of 250 ml closed with type I laminated chlorobutyl rubber stopper and aluminium cap in a carton box.
- Clear type II glass vial of 100 ml closed with type I laminated chlorobutyl rubber stopper and aluminium cap in a carton box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- Kela - Kempisch Laboratorium - Kela Laboratoria
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
- 4394/X/23 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0390/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
This information is not available for this product.
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: